N-ras mutations in adult de novo acute myelogenous leukemia: prevalence and clinical significance.
about
A critical function for B-Raf at multiple stages of myelopoiesisPrognostic impact of RAS mutations in patients with myelodysplastic syndrome.Down-regulation of microRNAs 222/221 in acute myelogenous leukemia with deranged core-binding factor subunitsPatients with acute myeloid leukemia and RAS mutations benefit most from postremission high-dose cytarabine: a Cancer and Leukemia Group B studyClinical and proteomic characterization of acute myeloid leukemia with mutated RAS.Small molecule inhibitors in acute myeloid leukemia: from the bench to the clinicTrisomy 11 as an isolated abnormality in acute myeloid leukemia is associated with unfavorable prognosis but not with an NPM1 or KIT mutation.Significance of KIT exon 17 mutation depends on mutant level rather than positivity in core-binding factor acute myeloid leukemiaHematopoietic cell fate and the initiation of leukemic properties in primitive primary human cells are influenced by Ras activity and farnesyltransferase inhibitionGenome-scale expression and transcription factor binding profiles reveal therapeutic targets in transgenic ERG myeloid leukemia.Cause and consequences of genetic and epigenetic alterations in human cancer.Apoptosis repressor with caspase recruitment domain is regulated by MAPK/PI3K and confers drug resistance and survival advantage to AML.Activated Ca2+/calmodulin-dependent protein kinase IIgamma is a critical regulator of myeloid leukemia cell proliferation.Prognostic Significance of NRAS Gene Mutations in Children with Acute Myelogenous Leukemia.KRAS overexpression independent of RAS mutations confers an adverse prognosis in cytogenetically normal acute myeloid leukemia.Clonal analysis of multiple point mutations in the N-ras gene in patients with acute myeloid leukemia.
P2860
Q28590150-901C1769-8623-43EE-9CA1-E19F2F7B8EBFQ33871210-176372C5-CA44-4FA6-BCAE-60450E4458E3Q34300594-AC7FC316-05A6-45F5-8764-96BC897863F4Q34593276-4B6FB214-326F-4B45-8FE9-416ABBDECA5EQ34638143-8799FD0B-C992-43B2-B807-2250F9BBE7FEQ34817365-704FB424-CBF6-478B-9794-2DF26DA6D3E1Q34976428-B1915670-01C3-47E2-A574-E1E7BE706228Q36548080-A70167B8-0078-42CC-BD77-357D2786F0B7Q36701461-A16B6204-F052-42C3-97B0-A298C8D53384Q37226744-633CF268-E1FB-472A-9243-2F097DF8F652Q37511752-166E3DBB-1674-40DB-8E1D-336C3A3DE1FDQ37619463-F4B20BD1-F195-4D01-8EFB-BC4D8727BC7EQ39681202-E7759736-A212-4BF9-8D7D-5DACC1845D0CQ40055219-3046759E-EB3A-4132-8F0E-F11D21BAB99EQ42371609-44476EC8-3AAA-44C5-9C97-E1B204997060Q54997337-07BCE422-0C50-4366-9A6F-E79445A0950C
P2860
N-ras mutations in adult de novo acute myelogenous leukemia: prevalence and clinical significance.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
N-ras mutations in adult de no ...... nce and clinical significance.
@en
N-ras mutations in adult de no ...... nce and clinical significance.
@nl
type
label
N-ras mutations in adult de no ...... nce and clinical significance.
@en
N-ras mutations in adult de no ...... nce and clinical significance.
@nl
prefLabel
N-ras mutations in adult de no ...... nce and clinical significance.
@en
N-ras mutations in adult de no ...... nce and clinical significance.
@nl
P2093
P1433
P1476
N-ras mutations in adult de no ...... ence and clinical significance
@en
P2093
Appelbaum F
Collins SJ
Kopecky KJ
Willman CL
P304
P407
P577
1990-08-01T00:00:00Z